Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $14.59 -0.32 (-2.15%) As of 10/23/2026 Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendFinancialsInsider TradesOptions ChainSEC Filings Aerovate Therapeutics Stock Price Performance The Aerovate Therapeutics (AVTE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 46.93%, with a year-to-date return of -6.20%. In the past month, the stock has decreased 0.82%, reflecting recent market activity. As of the latest close, Aerovate Therapeutics traded at $14.91 with a market cap of $432.17 million and volume of 575,925 shares. Five years ago, the stock traded at a split-adjusted price of $464.10, representing a 96.86% decrease over that period. At the time, it had a market cap of $323.68 million and a volume of 1,941 shares. Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+8.31%1 Month Performance-0.82%3 Month Performance-25.64%Year-To-Date Performance-6.20%1 Year Performance+46.93%5 Year Performance-96.86% AVTE Stock Chart for Saturday, October, 24, 2026 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Yearly Interval 9/24/2026 - 10/24/2026 Price Date Price Date From Price Date To 1M3M6MYTD1Y3Y5Y More filters Fewer filters Done 0 Results Export DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/23/2026$15.13$14.91-1.45%$15.44$14.36575,925 shs$432.17 million10/22/2026$14.86$15.13+1.82%$15.43$14.72932,727 shs$438.54 million10/21/2026$13.83$14.86+7.45%$14.96$13.73881,296 shs$430.72 million10/20/2026$13.47$13.83+2.67%$14.10$13.54828,514 shs$400.86 million10/19/2026$13.47$13.47$14.10$13.03981,008 shs$390.43 million10/16/2026$13.44$13.76+2.38%$14.18$13.451.04 million shs$398.83 million10/15/2026$13.42$13.44+0.15%$13.66$12.851.17 million shs$389.56 million10/14/2026$14.00$13.42-4.14%$14.24$13.351.33 million shs$388.98 million10/13/2026$14.39$14.00-2.71%$14.45$13.821.36 million shs$405.79 million10/12/2026$14.39$14.39$14.81$14.00735,600 shs$417.09 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/09/2026$13.77$14.15+2.76%$14.15$13.181.67 million shs$410.14 million10/08/2026$13.41$13.77+2.68%$14.14$13.08951,274 shs$399.12 million10/07/2026$14.07$13.41-4.69%$14.34$13.15493,865 shs$388.69 million10/06/2026$14.12$14.07-0.35%$14.71$13.79607,056 shs$407.82 million10/05/2026$14.12$14.12$14.17$13.311.11 million shs$409.27 million10/02/2026$14.05$13.77-1.99%$14.58$13.591.07 million shs$399.12 million10/01/2026$14.18$14.05-0.92%$14.74$13.95930,921 shs$407.24 million09/30/2026$14.35$14.18-1.18%$14.66$13.77629,653 shs$411.01 million09/29/2026$14.42$14.35-0.49%$14.71$14.08598,628 shs$415.94 million09/28/2026$14.42$14.42$15.20$14.39525,819 shs$417.96 million09/25/2026$14.71$14.73+0.14%$15.06$14.451.05 million shs$426.95 million09/24/2026$16.76$14.71-12.23%$16.64$14.581.46 million shs$426.37 million Related Companies Stoke Therapeutics Stock Chart Maze Therapeutics Stock Chart uniQure Stock Chart Ultragenyx Pharmaceutical Stock Chart Immunocore Stock Chart Kailera Therapeutics Stock Chart Syndax Pharmaceuticals Stock Chart Ascentage Pharma Group International Stock Chart Omeros Stock Chart Hemab Therapeutics Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredHow I’m playing the AI melt-up (and down)Porter Stansberry says a powerful new market shift is forming and most investors are missing it entirely. I...Porter & Company | SponsoredTrump's bank just got approvedLast month I told investors that a Trump-backed crypto bank could be approved any day. On August 14, it was...Crypto 101 Media | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredSpaceX is worth trillions. This one's $14.It is not SpaceX, Tesla, Starlink, or Neuralink. But Elon's rocket company shows up in this stock's paperwork,...Behind the Markets | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
